AbCellera Biologics (ABCL) Nyalo Cwiny me Stock
AI forecast: ABCL
AI otyeko kwena ya ceng ma lwenyo, gima agik juma, ki gima agik juma. Kwena en gima iyar ki neno kwena ma nyaka. Gin en neno ki kare, onyo nyutu ya yat.
Jaji e lweny e dwe 6 mag giko
Premium nyalo neno ceng'a AI me yweyo piyo ki 1 odiiyo, 1 juma ki 1 dwe ki gima onongo ki gikato ma okato.
Unlock Premium🔒 Nyinge yoo oryeto
Neno kare duto — forecast duto ma otyeko ki kwena ma otyeko — en pake Premium.
Unlock PremiumNyinge Aciya Man
AbCellera Biologics Inc. operates as a pharmaceutical company. The company researches and develops next-generation therapeutic antibodies using a combination of technologies, including patented immunizations, microfluidics, high-throughput imaging, genomics, computing, and laboratory automation. AbCellera Biologics serves customers in Canada.